Standout Papers
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) (2008)
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial (2012)
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer (2003)
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer (2003)
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer (2010)
- Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. (2000)
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy (2009)
- Prognostic Factors in Colorectal Cancer (2000)
- Guidelines 2000 for Colon and Rectal Cancer Surgery (2001)
- Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group Trial (2007)
- Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment (2004)
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? (2004)
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients (2001)
- Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials (2005)
- Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) (2008)
- Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database (2016)
- Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 (2011)
Immediate Impact
2 by Nobel laureates 7 from Science/Nature 84 standout
Citing Papers
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
2023 StandoutNature
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
Works of Daniel J. Sargent being referenced
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Optimising the design of phase II oncology trials: The importance of randomisation
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Daniel J. Sargent | 37110 | 11632 | 3148 | 17777 | 12411 | 474 | 57.2k | |
| Jaap Verweij | 27869 | 4537 | 805 | 21972 | 8677 | 619 | 54.4k | |
| Lawrence H. Schwartz | 20632 | 6756 | 550 | 20087 | 8158 | 386 | 50.1k | |
| Larry Rubinstein | 22032 | 2951 | 1894 | 19844 | 7219 | 195 | 46.6k | |
| Mithat Gönen | 25916 | 3540 | 974 | 18942 | 20330 | 769 | 58.9k | |
| Richard Kaplan | 22048 | 3794 | 871 | 19835 | 7599 | 171 | 45.0k | |
| Josep Tabernero | 33324 | 9222 | 357 | 14187 | 7861 | 1.1k | 49.1k | |
| Eric Van Cutsem | 68215 | 15802 | 636 | 35069 | 20117 | 1.2k | 92.5k | |
| Janet Dancey | 19412 | 3277 | 672 | 15054 | 5384 | 202 | 37.3k | |
| Seth M. Steinberg | 28549 | 7877 | 321 | 13347 | 6251 | 861 | 57.6k | |
| John D. Hainsworth | 21144 | 6869 | 271 | 12105 | 5165 | 623 | 36.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...